Lilly’s Climb Has Morgan Stanley Asking $1 Trillion Query
(Bloomberg) — Eli Lilly & Co.’s relentless inventory data have Morgan Stanley analysts musing whether or not it is going to transform the primary US corporate out of doors of the Magnificent